- Additional Authors
- Center for Biologics Evaluation and Research (U.S.)
- Description
- i, 13 pages : digital, PDF file
- Alternative Title
- Supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors
- Subject
- Note
- Title from PDF title page (viewed on May, 12, 2009).
- "November 2006."
- Bibliography (note)
- Includes bibliographical references (pages 10-11).
- System Details (note)
- Mode of access: Internet at the FDA CBER web site. Address as of 5/12/09: http://www.fda.gov/cber/gdlns/retrogt1000.pdf ; current access is available via PURL.
- Call Number
- GPO Internet HE 20.4802:R 31
- OCLC
- marcive320838766
- Title
Guidance for industry : supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors.
- Publisher
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- System Details
Mode of access: Internet at the FDA CBER web site. Address as of 5/12/09: http://www.fda.gov/cber/gdlns/retrogt1000.pdf ; current access is available via PURL.
- Bibliography
Includes bibliographical references (pages 10-11).
- Connect to:
- Added Author
Center for Biologics Evaluation and Research (U.S.)
- Gpo Item No.
0499-T-02 (online)
- Sudoc No.
HE 20.4802:R 31